| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Metabolic Medicine, Hammersmith Hospitals Trust (C.W.l.R., W.M.K., W.S.D., J.J., J.A.-Z.), London, United Kingdom W12 0NN; and Department of Anesthesiology, Bradford Royal Infirmary (G.A.C.), Bradford, United Kingdom
Address all correspondence and requests for reprints to: Dr. Carel le Roux, Department of Metabolic Medicine, Hammersmith Hospital, London, United Kingdom W12 0NN. E-mail: c.leroux{at}ic.ac.uk.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
We have previously shown that variation in cortisol-binding globulin (CBG) can significantly affect serum cortisol levels in healthy volunteers (8). Patients in the ICU typically show an acute phase response associated with a substantial fall in CBG (9, 10), and this may explain the difficulties in interpreting serum total cortisol values in patients in the ICU.
Serum total cortisol is approximately 80% bound to serum CBG and 10% bound to serum albumin (11). The free cortisol index (FCI), which is the serum total cortisol/CBG ratio, has been shown to correlate with serum free cortisol, which is the biologically active component (12).
We hypothesized that in situations associated with an acute phase response, serum total cortisol might not be an accurate indication of maximal HPA axis reserve, because of the changes in CBG. In 1967 Plumpton and Besser (13) used major surgery to validate the insulin tolerance test. We therefore evaluated the HPA axis response to major elective surgery, which produces both severe stress and an acute phase response, in a controlled environment. We hypothesized that the FCI would be a better indication of HPA axis reserve than serum total cortisol.
| Subjects and Methods |
|---|
|
|
|---|
Twenty-one females and 10 males undergoing major elective surgery were investigated. Females receiving estrogen therapy, patients with known endocrine disease, patients receiving any steroid preparation, and patients receiving etomidate (which has been reported to suppress adrenal function) (14) were excluded. All patients were assessed preoperatively by an anesthetist and were considered fit for surgery (American Society Anesthetists score <2). All surgical procedures were scheduled between 08301000 h, and the patients were recumbent for more than 30 min before surgery commenced. Venous blood was obtained preoperatively, approximately 5 min before intubation, and postoperatively, within 5 min after extubation. Full ethical approval was obtained, and the patients gave written informed consent.
Methods
Serum total cortisol was measured using an ELISA technique (ES700, Roche, Lewes, UK) with a coefficient of variation of 3% at 498 nmol/liter. Serum CBG was measured by RIA (Biosource Technologies, Inc. Europe S.A., Nivelle, Belgium) with a coefficient of variation of 3.8% at 62.2 mg/liter. The FCI was calculated by serum total cortisol/CBG (nanomoles/milligrams). We have previously shown that a normal 30-min FCI response to a standard 250 µg tertracosactrin is 12 or more (8).
Serum albumin was measured using an automated clincal chemistry analyzer (AU600, Olympus Corp., London, UK) with a coefficient of variation of 2.6% at 38 g/liter. The cortisol/albumin ratio was calculated by serum total cortisol/albumin (nanomoles/grams). Hemoglobin was measured using a Cell Dyn 4000 (Abbott Diagnostics, Maidenhead, UK) with a coefficient of variation of 1% at 12.1 g/dl.
Statistics
Values shown are the mean ± SEM, with the range of values shown in parentheses. Statistical analysis was performed using the SigmaStat package (SPSS, Inc., Chicago, IL). For continuously normally distributed data the paired t test was used to evaluate within-patient differences between pre- and postoperative values, and the unpaired t test was used to evaluate between-subject differences. The Mann-Whitney rank-sum test was used to evaluate differences in the maximal FCI and increase in FCI between the subgroup of patients who did not have a maximal response of cortisol above 500 nmol/liter and the rest of the group. The Pearson product-moment correlation coefficient was used for the correlation between serum total cortisol and FCI.
| Results |
|---|
|
|
|---|
|
|
|
|
The cortisol/albumin ratio was calculated in all postoperative samples in every patient (mean, 23.5 ± 1.9 nmol/g; range, 13.764.2) and correlated with the FCI (r2 = 0.73, P < 0.001).
The rate of decrease in CBG was evaluated in three patients by obtaining venous blood samples every 30 min during their respective laparotomies, which lasted, 90, 150, and 150 min, respectively. Table 4
shows that postoperative serum total cortisol rose by 108%; however, the FCI increased by 164%, reflecting a 27% fall in CBG. Most of the fall in CBG occurred in the first 30 min, and the total cortisol started rising between 30 and 60 min and was near or at a maximum at the end of the operation. The FCI showed the most dramatic increase between 30 and 60 min and was never less than 12.4 nmol/mg.
|
| Discussion |
|---|
|
|
|---|
Major elective surgery is a severe stress that occurs in a controlled environment. Our decision to use major surgery was also based on the fact that it was the reference against which the insulin tolerance test was validated (13). No data exist on the serum free cortisol response to major surgery or the minimum serum free cortisol requirement to survive such a stress. Any cut-off points for serum total cortisol after dynamic function tests also remain controversial (15). A value for serum total cortisol less than 500 or 550 nmol/liter (depending on assay used) after dynamic function testing has been proposed to demonstrate HPA axis insufficiency (15). Seven patients (23%) had inadequate cortisol responses if the criterion of 500 nmol was applied, and if the criterion of 550 nmol/liter were applied, 10 patients (32%) would have been classified with HPA insufficiency. The 7 patients had no history of steroid use or pathology affecting the HPA axis. Further, all made uneventful recoveries, with no evidence of HPA insufficiency.
The serum total cortisol response did not seem to be a true reflection of the maximal HPA axis reserve. The most likely explanation for the unexpectedly low total cortisol levels is the dramatic fall in CBG seen in these patients. The fall was presumably part of the acute phase response (9, 10). The dramatic fall in CBG during major elective surgery in this study mirrored that in serum albumin and was not correlated with hemoglobin changes and therefore was unlikely to be due to dilutional effect. The intraoperative fluids were also restricted because the patients were adequately hydrated for the elective surgical procedures in which no significant blood loss occurred. The percentage decrease in hemoglobin is much less than the percentage decrease in CBG or albumin. Similar changes in serum CBG are also likely to occur in most patients admitted to the ICU, and this study demonstrated that variable serum CBG could influence the interpretation of serum total cortisol.
CBG and T4-binding globulin are members of the serine protease inhibitor (serpin) superfamily and are vulnerable to proteolytic cleavage (16). The reason for the decrease in CBG, like that in albumin, could, however, be due to several factors during the acute phase response, including increased permeability of vasculature (17), decreased liver production (17), or degradation by elastase (18). The measurement of serum total cortisol is therefore difficult to interpret in patients postoperatively or when on the ICU, where CBG is likely to change substantially. Measurement of serum free cortisol would overcome this problem, but is not available for routine clinical use. Our results suggest that CBG concentrations must be considered when interpreting total cortisol results in this context.
We corrected for variations in CBG using the FCI. The FCI as a surrogate for the serum free cortisol showed a consistent response in all patients above 13, and this is similar to the FCI response of 12 or above found in healthy volunteers undergoing an SST (8). Furthermore, there was no difference in the FCI between patients with postoperative cortisol above or below 500 nmol/liter. The absolute value for the cortisol/albumin ratio is above 13.7 nmol/g for all patients postoperatively, and this may be a useful clinical marker to decide whether measuring CBG is justified to calculate the FCI. Albumin is also subject to other influences, however, which fall outside the spectrum of this study.
Our results suggest that decisions based on total serum cortisol, especially in acutely ill patients, may be improved by taking into account the influence of binding proteins. It would be ideal to have an accurate and precise measurement of serum free cortisol; however, current serum free cortisol assays are too time consuming for routine clinical use. Therefore, in the absence of routine measurement of free cortisol we propose that CBG should be measured and used to correct total cortisol by calculating the FCI. Comparison of the FCI with free cortisol in healthy volunteers has shown that FCI is a satisfactory surrogate (12), but evaluation in clinically relevant situations will be important in establishing its future role.
The implications of this study extend to any situation where an acute phase response is present, especially after surgery and in patients admitted to the ICU. The interpretation of cut-off values after insulin tolerance or SSTs should also be evaluated in light of these findings, with particular interest in patients receiving exogenous estrogen therapy, in whom elevated CBG levels are seen (19).
This study demonstrates the limitations of serum total cortisol in situations when CBG changes significantly. Twenty-three percent of the patients evaluated would have been misdiagnosed with HPA axis insufficiency if current criteria were used. The FCI provides a simple and accurate way of evaluating the HPA axis reserve in such situations.
| Footnotes |
|---|
Received October 2, 2002.
Accepted February 10, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. M. Arafah, F. J. Nishiyama, H. Tlaygeh, and R. Hejal Measurement of Salivary Cortisol Concentration in the Assessment of Adrenal Function in Critically Ill Subjects: A Surrogate Marker of the Circulating Free Cortisol J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2965 - 2971. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mishra, N. Gupta, and R. Goswami Plasma Adrenocorticotropin (ACTH) Values and Cortisol Response to 250 and 1 {micro}g ACTH Stimulation in Patients with Hyperthyroidism before and after Carbimazole Therapy: Case-Control Comparative Study J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1693 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christ-Crain, S. Jutla, I. Widmer, O. Couppis, C. Konig, H. Pargger, J. Puder, R. Edwards, B. Muller, and A. B. Grossman Measurement of Serum Free Cortisol Shows Discordant Responsivity to Stress and Dynamic Evaluation J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1729 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Klose, M. Lange, A. K. Rasmussen, N. E. Skakkebaek, L. Hilsted, E. Haug, M. Andersen, and U. Feldt-Rasmussen Factors Influencing the Adrenocorticotropin Test: Role of Contemporary Cortisol Assays, Body Composition, and Oral Contraceptive Agents J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1326 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Arafah Hypothalamic Pituitary Adrenal Function during Critical Illness: Limitations of Current Assessment Methods J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3725 - 3745. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bousquet-Melou, E. Formentini, N. Picard-Hagen, L. Delage, V. Laroute, and P.-L. Toutain The Adrenocorticotropin Stimulation Test: Contribution of a Physiologically Based Model Developed in Horse for Its Interpretation in Different Pathophysiological Situations Encountered in Man Endocrinology, September 1, 2006; 147(9): 4281 - 4291. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Carroll, E. L. Berg, T. A. Strauch, M. P. Roberts, and H. G. Kattesh Hormonal profiles, behavioral responses, and short-term growth performance after castration of pigs at three, six, nine, or twelve days of age J Anim Sci, May 1, 2006; 84(5): 1271 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Brundu, T. L. Loucks, L. J. Adler, J. L. Cameron, and S. L. Berga Increased Cortisol in the Cerebrospinal Fluid of Women with Functional Hypothalamic Amenorrhea J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1561 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. den Brinker, K. F. M. Joosten, O. Liem, F. H. de Jong, W. C. J. Hop, J. A. Hazelzet, M. van Dijk, and A. C. S. Hokken-Koelega Adrenal Insufficiency in Meningococcal Sepsis: Bioavailable Cortisol Levels and Impact of Interleukin-6 Levels and Intubation with Etomidate on Adrenal Function and Mortality J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5110 - 5117. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E. Widmer, J. J. Puder, C. Konig, H. Pargger, H. R. Zerkowski, J. Girard, and B. Muller Cortisol Response in Relation to the Severity of Stress and Illness J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4579 - 4586. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Heo, H. G. Kattesh, M. P. Roberts, J. L. Morrow, J. W. Dailey, and A. M. Saxton Hepatic corticosteroid-binding globulin (CBG) messenger RNA expression and plasma CBG concentrations in young pigs in response to heat and social stress J Anim Sci, January 1, 2005; 83(1): 208 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Hamrahian, T. S. Oseni, and B. M. Arafah Measurements of Serum Free Cortisol in Critically Ill Patients N. Engl. J. Med., April 15, 2004; 350(16): 1629 - 1638. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |